Back
LYFE SCIENCES
Project: HERA
NM_012433.2:c.1876A>G
p.Asn626Asp  ·  SF3B1
ACMG/AMP
Starting
Initialising…
0%
Legacy Engine
Ready
View Legacy →
Classification rationale
1

The SF3B1 c.1876A>G (p.Asn626Asp; p.N626D) variant has been curated as a somatic cancer variant in OncoKB and has not been reported in ClinVar.

oncokb ↗ clinvar ↗
2

This variant is rare in population databases, with gnomAD v2.1 showing 1/251158 alleles (0.00040%) and gnomAD v4.1 showing 8/1613994 alleles (0.00050%; grpmax FAF 0.000124%), which is below the 0.1% PM2 threshold.

gnomad_v2 ↗ gnomad_v4 ↗
3

In silico results are mixed: SpliceAI predicts no significant splice impact (maximum delta score 0.08), while REVEL is 0.60 and BayesDel is -0.0733292, so computational evidence does not independently support PP3 or BP4.

spliceai ↗
Applied criteria
Met
Not met
Not assessed
N/A
Very strong
Strong
Moderate
Supporting
Pathogenic evidence
PVS
PVS1
PS
PS1
PS2
PS3
PS4
PM
PM1
PM2
PM3
PM4
PM5
PM6
PP
PP1
PP2
PP3
PP4
PP5
Benign evidence
BA
BA1
BS
BS1
BS2
BS3
BS4
BP
BP1
BP2
BP3
BP4
BP5
BP6
BP7
PVS1
—
—
Rationale
Select a criterion to inspect its explanation.
Evidence used
  • —
Gaps remaining
  • —
Rule
—
Publications
—
Research and evidence
gnomAD v2.1 evidence
v2.1
gnomAD v4.1 evidence
v4.1
01
Population
gnomAD v2.1This variant is present in gnomAD v2.1 (AF= 3.98156e-06; MAF= 0.00040%, 1/251158 alleles, homozygotes = 0) and has highest observed frequency in the Admixed American population (AF= 2.89385e-05; MAF= 0.00289%, 1/34556 alleles, homozygotes = 0).
gnomAD v4.1This variant is present in gnomAD v4.1 (AF= 4.95665e-06; MAF= 0.00050%, 8/1613994 alleles, homozygotes = 0) and has highest observed frequency in the Remaining individuals population (AF= 3.20092e-05; MAF= 0.00320%, 2/62482 alleles, homozygotes = 0); grpmax FAF= 1.24e-06.
gnomAD v2 ↗ gnomAD v4 ↗
ClinVar evidence
02
ClinVar
This variant is absent from ClinVar.
ClinVar ↗
Functional evidence
03
Functional
OncoKB: Likely Oncogenic
OncoKB identified variant-specific curated literature and context relevant to functional review; curated oncogenicity label: Likely Oncogenic.
OncoKB ↗
In silico evidence
04
In silico
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.08). REVEL score = 0.6. BayesDel score = -0.0733292.
SpliceAI ↗
COSMIC evidence
05
COSMIC
This variant lies in a statistically significant hotspot. This variant has previously been reported in somatic cancers (COSMIC; COSV59206442, n = 12 times).
COSMIC ↗
Cancer hotspots evidence
06
Cancer hotspots Not found
This variant lies in a statistically significant hotspot.
ResidueN626
Hotspots ↗